EUVIMEDEUVIMED entdecken
Crossref

Ionic reverberation modulates the cellular fate of CD8+tissue resident memory T cells (TRMs) in patients with renal cell carcinoma: A novel mechanism

Ashu Singh, Saumitra Dey Choudhury, Prabhjot Singh, Vishwendra Vikram Singh, Som Nath Singh, Alpana Sharma

Clinical Immunology · 2024

DOI: 10.1016/j.clim.2024.110256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Immunology, 2024. Verfasst von Ashu Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, CD8-Positive T-Lymphocytes, Memory T Cells. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In metastatic renal cell carcinoma (mRCC), existing treatments including checkpoint inhibitors are failed to cure and/or prevent recurrence of the disease. Therefore, in-depth understanding of tumor tissue resident memory T cells (TRMs) dysfunction are necessitated to enrich efficacy of immunotherapies and increasing disease free survival in treated patients. In patients, we observed dysregulation of K+, Ca2+, Na2+ and Zn2+ ion channels leads to excess infiltration of their respective ions in tumor TRMs, thus ionic gradients are disturbed and cells became hyperpolarized. Moreover, overloaded intramitochondrial calcium caused mitochondrial depolarization and trigger apoptosis of tumor TRMs. Decreased prevalence of activated tumor TRMs reflected our observations. Furthermore, disruptions in ionic concentrations impaired the functional activities and/or suppressed anti-tumor action of circulating and tumor TRMs in RCC. Collectively, these findings revealed novel mechanism behind dysfunctionality of tumor TRMs. Implicating enrichment of activated TRMs within tumor would be beneficial for better management of RCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsCD8-Positive T-LymphocytesMemory T CellsHumansImmunologic MemoryMaleFemaleMiddle AgedIon ChannelsAged

Stichwörter der Autor:innen

Ca(2+)K(+)Na(2+)TMETRMsZn(2+)mRCC

Substanzen

Ion Channels

Autor:innen und Institutionen

  • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
  • Central core Research facility, All India Institute of Medical Sciences, New Delhi, India.
  • Department of Urology, All India Institute of Medical Sciences, New Delhi, India.
  • Defence Institute of Physiology and Allied Sciences, New Delhi, India.
  • Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India. Electronic address: dralpanasharma@aiims.edu.

Förderung

  • Council of Scientific and Industrial Research, India

Zitieren

APA

Singh, A., Choudhury, S. D., Singh, P., Singh, V. V., Singh, S. N., & Sharma, A. (2024). Ionic reverberation modulates the cellular fate of CD8+tissue resident memory T cells (TRMs) in patients with renal cell carcinoma: A novel mechanism. Clinical Immunology. https://doi.org/10.1016/j.clim.2024.110256

Vancouver

Singh A, Choudhury SD, Singh P, Singh VV, Singh SN, Sharma A. Ionic reverberation modulates the cellular fate of CD8+tissue resident memory T cells (TRMs) in patients with renal cell carcinoma: A novel mechanism. Clinical Immunology. 2024. doi:10.1016/j.clim.2024.110256

BibTeX
@article{Singh2024,
  author = {Singh, Ashu and Choudhury, Saumitra Dey and Singh, Prabhjot and Singh, Vishwendra Vikram and Singh, Som Nath and Sharma, Alpana},
  title = {Ionic reverberation modulates the cellular fate of CD8+tissue resident memory T cells (TRMs) in patients with renal cell carcinoma: A novel mechanism},
  journal = {Clinical Immunology},
  year = {2024},
  doi = {10.1016/j.clim.2024.110256}
}
Kostenlos starten →